Latest Press Releases

Health News Posted on Monday, December 23, 2024

Premium Press Releases »

OBI Pharma Enters Collaboration with GlyTech to Expand GlycOBI® Enabling Technologies Outreach in Japan and to Advance Glycan Production

TAIPEI, Taiwan, Dec. 23, 2024 (GLOBE NEWSWIRE) -- OBI Pharma, Inc. (OBI), a clinical-stage global oncology company specialized in the development of novel cancer therapies such as antibody-drug conjugates (ADC) and active immunotherapies (4174. ...

Read More

KFSHRC Inaugurates MENA’s Most Advanced Hematology Diagnostics Laboratory

RIYADH, Saudia Arabia, Dec. 19, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) inaugurated the Advanced Hematology Diagnostics Laboratory under the patronage of Deputy CEO Dr. Björn Zoéga. The ...

Read More

Mitolyn Reviews (Purple Peel Exploit For Weight Loss) Satisfied Customer Results or Fake Hype?

Mitolyn is a natural dietary supplement designed to support individuals struggling with stubborn body fat. It contains natural ingredients that address the root cause of weight gain and accelerate the metabolism to support fat burning. The ...

Read More

Press Releases »

Aptamer developed by HKBU for treating rare bone disease 'X-linked hypophosphatemia' receives Orphan Drug Designation and Rare Pediatric Disease Designation by U.S. FDA

PR Newswire HONG KONG, Dec. 23, 2024 HONG KONG, Dec. 23, 2024 /PRNewswire/ -- A research led by Hong Kong Baptist University (HKBU) and the Shanghai Sixth People's Hospital Affiliated to School of Medicine at Shanghai Jiao Tong University ...

Read More

CStone Announces Submission of Clinical Trial Application in Australia for CS2009, an Innovative PD-1/VEGF/CTLA-4 Trispecific Antibody

PR Newswire SHANGHAI, Dec. 22, 2024 SHANGHAI, Dec. 22, 2024 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of anti-cancer therapies, ...

Read More

Steps to Take After a Bicycle Accident: Protecting Your Rights

PR Newswire FORT LAUDERDALE, Fla., Dec. 22, 2024 FORT LAUDERDALE, Fla., Dec. 22, 2024 /PRNewswire/ -- Bicycle accidents can leave victims with severe injuries and uncertainty about what steps to take next. The Law Offices of Jason Turchin ...

Read More

Second Opinion Expert Announces Filing of U.S. Patent for Method of Generating Medical Opinions Using Artificial Intelligence

PR Newswire DANA POINT, Calif., Dec. 22, 2024 Patent leverages AI technology to improve patient outcomes and reduce cost of care DANA POINT, Calif., Dec. 22, 2024 /PRNewswire-PRWeb/ -- SecondOpinionExpert, Inc. (SOE), a leading ...

Read More

Registration Is Now Open for Women's Health and Menopause, a Continuing Medical Education Course Offered by Harvard Medical School and Mass General Brigham

PR Newswire BOSTON, Dec. 21, 2024 Course Director: Deborah Gomez Kwolek, MD, FACP, FAMWA, MSCP and Course Co-Director: Mahmooda Qureshi, MD, MSCP Join keynote speakers Jan L. Shifren, MD, MSCP, Anna Cabeca, DO, FACOG, ABAARM, Heather Hirsch, ...

Read More

Vintage Philanthropy: Hollander Foundation Pours $25,000 into Prostate Cancer Research from Wine-Making Proceeds

PR Newswire GAINESVILLE, Fla., Dec. 21, 2024 The Hollander Foundation, dedicated to supporting prostate cancer research, awarded its annual gift to Franklin Huang, M.D. of the UCSF School of Medicine. Dr. Huang's lab examines the genetics of ...

Read More

YolTech Therapeutics Announces Successful Completion of Dose Escalation Phase in Phase I Trial of YOLT-201 for ATTR

PR Newswire SHANGHAI, Dec. 21, 2024 SHANGHAI, Dec. 21, 2024 /PRNewswire/ -- YolTech Therapeutics today announced updated data from its ongoing Phase I/IIa clinical trial of YOLT-201, a first-in-class CRISPR/Cas9-based in vivo gene-editing ...

Read More

FDA approves Alhemo® injection as once-daily prophylactic treatment to prevent or reduce the frequency of bleeding episodes for adults and children 12 years of age and older with hemophilia A or B with inhibitors

PR Newswire PLAINSBORO, N.J., Dec. 20, 2024 PLAINSBORO, N.J., Dec. 20, 2024 /PRNewswire/ -- Novo Nordisk announced today that the U.S. Food and Drug Administration (FDA) approved Alhemo® (concizumab-mtci) injection as a once-daily ...

Read More

FDA Approves First Medication for Obstructive Sleep Apnea

PR Newswire SILVER SPRING, Md., Dec. 20, 2024 SILVER SPRING, Md., Dec. 20, 2024 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea ...

Read More

FDA approves Zepbound® (tirzepatide) as the first and only prescription medicine for moderate-to-severe obstructive sleep apnea in adults with obesity

PR Newswire INDIANAPOLIS, Dec. 20, 2024  Averaging up to 20% of weight loss, adults taking Zepbound had at least 25 fewer breathing interruptions each hour as they slept Up to 50% of adults taking Zepbound no longer had symptoms ...

Read More

Study Finds Telemedicine Improves Care for Children with Eye Cancer

PR Newswire NEW YORK, Dec. 20, 2024 The new research from eye care nonprofit Orbis International, supported by Heidelberg Engineering, shows how telemedicine improves outcomes for children with retinoblastoma through e-learning and virtual ...

Read More

Oncology Advancements Accelerate Amid Rising Early-Onset Cancer Diagnoses

PR Newswire VANCOUVER, BC, Dec. 20, 2024 USA News Group CommentaryIssued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Dec. 20, 2024 /PRNewswire/ -- USA News Group News Commentary – The American Cancer Society has published its ...

Read More

Samsung invests in Generate: Biomedicines to advance AI-driven protein therapeutics discovery

PR Newswire INCHEON, South Korea, Dec. 18, 2024 - Samsung Life Science Fund invests in Generate:Biomedicines, a Flagship Pioneering company leading in AI-enabled protein therapeutics discovery and development - Investment highlights ...

Read More

TRYNGOLZA™ (olezarsen) approved in U.S. as first-ever treatment for adults living with familial chylomicronemia syndrome as an adjunct to diet

PR Newswire CARLSBAD, Calif., Dec. 19, 2024 CARLSBAD, Calif., Dec. 19, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that the U.S. Food and Drug Administration (FDA) has approved TRYNGOLZA™ (olezarsen) as an ...

Read More

Pharus Diagnostics LLC Announces Validation of a Laboratory-Developed Test for Early Pancreatic Cancer Detection

PR Newswire LOS ANGELES, Dec. 18, 2024 LOS ANGELES, Dec. 18, 2024 /PRNewswire/ -- Pharus Diagnostics LLC. (PharusDx), an innovator in non-invasive diagnostic tests, today announced a significant step forward in the fight against pancreatic ...

Read More

Breckenridge announces final FDA approval for Methadone Hydrochloride Multi-Dose Injection

PR Newswire BERKELEY HEIGHTS, N.J., Dec. 18, 2024 BERKELEY HEIGHTS, N.J., Dec. 18, 2024 /PRNewswire/ -- Breckenridge Pharmaceutical, Inc., the U.S. subsidiary of Towa International that markets, distributes, and sells generic pharmaceuticals ...

Read More

Syrian American Medical Society (SAMS) Reaffirms Commitment to Syria's Health Crisis Amid Continued Power Transition

PR Newswire WASHINGTON, Dec. 18, 2024 Volunteer Doctors Introduce Health Assessment Report, Outlining Urgent Medical Solutions for Syria WASHINGTON, Dec. 18, 2024 /PRNewswire/ -- The Syrian American Medical Society (SAMS), global leader ...

Read More

CND Life Sciences Announces Publication of Study Demonstrating Clinical Utility of the Syn-One Test® as an Important Aid in the Diagnosis and Treatment of Neurodegenerative Diseases

PR Newswire SCOTTSDALE, Ariz., Dec. 18, 2024 Findings from retrospective chart review of patients with suspected Parkinson's disease and related disorders show the use of skin biopsy for detection of abnormal synuclein in cutaneous nerves ...

Read More

Karmanos Cancer Institute Physicians Begin Prescribing New FDA-approved Radiofrequency Electromagnetic Device to Treat Advanced Liver Cancer

PR Newswire DETROIT, Dec. 18, 2024 Karmanos is the first in the world with access to this innovative treatment that uses radiofrequencies to target and shrink cancerous tumors DETROIT, Dec. 18, 2024 /PRNewswire/ -- The Barbara Ann ...

Read More

MHA Issues New Report on Social Media and Youth Mental Health

PR Newswire ALEXANDRIA, Va., Dec. 18, 2024 Co-authored by young leaders, "Breaking the Algorithm" outlines recommendations to promote healthier experiences across digital platforms ALEXANDRIA, Va., Dec. 18, 2024 /PRNewswire/ -- Mental ...

Read More

Immorta Bio Advances Lung Cancer Immunotherapy with Peer-Reviewed Animal Data on Senolytic Vaccine

PR Newswire MIAMI, Dec. 18, 2024 Breakthrough Study Highlights SenoVax™'s Potential to Transform Cancer Treatment MIAMI, Dec. 18, 2024 /PRNewswire/ -- Immorta Bio Inc., a leader in longevity-focused biotechnologies, has announced the ...

Read More

Therapeutic Drug Monitoring Market to Hit USD 3.44 Billion by 2029 with 8.4% CAGR | MarketsandMarkets™

PR Newswire DELRAY BEACH, Fla., Dec. 18, 2024 DELRAY BEACH, Fla., Dec. 18, 2024 /PRNewswire/ -- The global therapeutic drug monitoring market would expand at a compound annual growth rate (CAGR) of 8.4% from USD 2.30 billion in 2024 to USD ...

Read More

Lucia Health Guidelines Initiates Clinical Study Evaluating its Lucia Health Coach Generative AI Agent for Educating and Supporting Patients with Atrial Fibrillation

PR Newswire SAN DIEGO, Dec. 18, 2024 Pilot study testing innovative agent designed to provide guideline-concordant education believed to be the first clinical study to evaluate an AI Agent with actual AFib patients SAN DIEGO, Dec. ...

Read More

Abilita Therapeutics and Orion Announce Research Collaboration to Develop Next-Generation Antibody Therapeutics in the Areas of Oncology and Pain

PR Newswire SAN DIEGO, Dec. 18, 2024 SAN DIEGO, Dec. 18, 2024 /PRNewswire/ -- Abilita Therapeutics, Inc. ("Abilita") today announced a global licensing and multi-target research collaboration with Finnish Orion Corporation ("Orion") focused ...

Read More

North Pole Nightmare Before Christmas

PR Newswire NORTH POLE, Alaska, Dec. 18, 2024 Naughty Canine Eats Santa's Head NORTH POLE, Alaska, Dec. 18, 2024 /PRNewswire/ -- Puppies will find and eat anything, even at the North Pole. Few, however, make a direct assault on the big ...

Read More

American Skin Association (ASA) Renews Partnership with SPOTS, an Awarding-Winning Educational Program Promoting Skin Health Awareness

PR Newswire NEW YORK, Dec. 18, 2024 NEW YORK, Dec. 18, 2024 /PRNewswire/ -- American Skin Association (ASA) is pleased to announce its renewed partnership with the Sun Protection Outreach Teaching by Students (SPOTS) program. SPOTS is an ...

Read More

PsychPlus to Accelerate Nationwide Expansion of Revolutionary Mental Health Ecosystem Targeting 20 New Markets in 2025 and Reducing the National Suicide Rate

PR Newswire HOUSTON, Dec. 18, 2024 PsychPlus, a pioneering leader in mental health care with a vision to reduce the national suicide rate, is taking bold steps toward transforming the U.S. mental health landscape. The company, distinguished ...

Read More

MNA Nurses of Salem Hospital Reach Tentative Contract Agreement to Help Protect Patient Care Quality by Respecting and Investing in Nurses

PR Newswire SALEM, Mass., Dec. 18, 2024 The tentative agreement follows a powerful informational picket by nurses in October that pushed Mass General Brigham to stabilize the Salem RN workforce SALEM, Mass., Dec. 18, 2024 /PRNewswire/ -- ...

Read More

Free burgers through Christmas? How about Free Health Year-Round?

PR Newswire CHANHASSEN, Minn., Dec. 18, 2024 Life Time takes on fast food frenzy with free consumer app to support healthy living CHANHASSEN, Minn., Dec. 18, 2024 /PRNewswire/ -- Countering the latest fast-food frenzy of free giveaways ...

Read More

Alexion, AstraZeneca Rare Disease reaches an agreement with the pan-Canadian Pharmaceutical Alliance (pCPA) for Koselugo (selumetinib) for the treatment of paediatric patients with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas (PN)

Canada NewsWire MISSISSAUGA, ON, Dec. 18, 2024 The agreement is a critical step in ensuring paediatric patients living with NF1 PN have public access to Koselugo, the only approved therapy in Canada for this rare disease MISSISSAUGA, ON, ...

Read More
More Press Releases

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.